Cargando…
An α-chloroaldehyde-based formal synthesis of eribulin
Eribulin (Halaven) is the most structurally complex non-peptidic drug made by total synthesis and has challenged preconceptions of synthetic feasibility in drug discovery and development. However, despite decades of research, the synthesis and manufacture of eribulin remains a daunting task. Here, w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076431/ https://www.ncbi.nlm.nih.gov/pubmed/37019928 http://dx.doi.org/10.1038/s41467-023-37346-7 |
_version_ | 1785020129969438720 |
---|---|
author | Kaghad, Anissa Panagopoulos, Dimitrios Caballero-García, Guillermo Zhai, Huimin Britton, Robert |
author_facet | Kaghad, Anissa Panagopoulos, Dimitrios Caballero-García, Guillermo Zhai, Huimin Britton, Robert |
author_sort | Kaghad, Anissa |
collection | PubMed |
description | Eribulin (Halaven) is the most structurally complex non-peptidic drug made by total synthesis and has challenged preconceptions of synthetic feasibility in drug discovery and development. However, despite decades of research, the synthesis and manufacture of eribulin remains a daunting task. Here, we report syntheses of the most complex fragment of eribulin (C14–C35) used in two distinct industrial routes to this important anticancer drug. Our convergent strategy relies on a doubly diastereoselective Corey–Chaykovsky reaction to affect the union of two tetrahydrofuran-containing subunits. Notably, this process relies exclusively on enantiomerically enriched α-chloroaldehydes as building blocks for constructing the three densely functionalized oxygen heterocycles found in the C14–C35 fragment and all associated stereocenters. Overall, eribulin can now be produced in a total of 52 steps, which is a significant reduction from that reported in both academic and industrial syntheses. |
format | Online Article Text |
id | pubmed-10076431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100764312023-04-07 An α-chloroaldehyde-based formal synthesis of eribulin Kaghad, Anissa Panagopoulos, Dimitrios Caballero-García, Guillermo Zhai, Huimin Britton, Robert Nat Commun Article Eribulin (Halaven) is the most structurally complex non-peptidic drug made by total synthesis and has challenged preconceptions of synthetic feasibility in drug discovery and development. However, despite decades of research, the synthesis and manufacture of eribulin remains a daunting task. Here, we report syntheses of the most complex fragment of eribulin (C14–C35) used in two distinct industrial routes to this important anticancer drug. Our convergent strategy relies on a doubly diastereoselective Corey–Chaykovsky reaction to affect the union of two tetrahydrofuran-containing subunits. Notably, this process relies exclusively on enantiomerically enriched α-chloroaldehydes as building blocks for constructing the three densely functionalized oxygen heterocycles found in the C14–C35 fragment and all associated stereocenters. Overall, eribulin can now be produced in a total of 52 steps, which is a significant reduction from that reported in both academic and industrial syntheses. Nature Publishing Group UK 2023-04-05 /pmc/articles/PMC10076431/ /pubmed/37019928 http://dx.doi.org/10.1038/s41467-023-37346-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Kaghad, Anissa Panagopoulos, Dimitrios Caballero-García, Guillermo Zhai, Huimin Britton, Robert An α-chloroaldehyde-based formal synthesis of eribulin |
title | An α-chloroaldehyde-based formal synthesis of eribulin |
title_full | An α-chloroaldehyde-based formal synthesis of eribulin |
title_fullStr | An α-chloroaldehyde-based formal synthesis of eribulin |
title_full_unstemmed | An α-chloroaldehyde-based formal synthesis of eribulin |
title_short | An α-chloroaldehyde-based formal synthesis of eribulin |
title_sort | α-chloroaldehyde-based formal synthesis of eribulin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076431/ https://www.ncbi.nlm.nih.gov/pubmed/37019928 http://dx.doi.org/10.1038/s41467-023-37346-7 |
work_keys_str_mv | AT kaghadanissa anachloroaldehydebasedformalsynthesisoferibulin AT panagopoulosdimitrios anachloroaldehydebasedformalsynthesisoferibulin AT caballerogarciaguillermo anachloroaldehydebasedformalsynthesisoferibulin AT zhaihuimin anachloroaldehydebasedformalsynthesisoferibulin AT brittonrobert anachloroaldehydebasedformalsynthesisoferibulin AT kaghadanissa achloroaldehydebasedformalsynthesisoferibulin AT panagopoulosdimitrios achloroaldehydebasedformalsynthesisoferibulin AT caballerogarciaguillermo achloroaldehydebasedformalsynthesisoferibulin AT zhaihuimin achloroaldehydebasedformalsynthesisoferibulin AT brittonrobert achloroaldehydebasedformalsynthesisoferibulin |